G2GBIO Inc. (KOSDAQ:456160)
South Korea · Delayed Price · Currency is KRW 42,000
-2,700 (-6.04%)
At close: Oct 8, 2026
G2GBIO Market Cap
G2GBIO has a market cap or net worth of 698.44 billion as of October 8, 2026. It is the 14,452nd most valuable company in the world and the 390th biggest in South Korea. Its market cap has decreased by 35.08% in one year.
Market Cap
698.44B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#390 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 14, 2025, G2GBIO's market cap has increased from 503.30B to 698.44B, an increase of 38.77%. That is a compound annual growth rate of 32.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 698.44B | -36.52% |
| Dec 30, 2025 | 1.10T | 118.59% |
| Aug 14, 2025 | 503.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 314.88B |
| HEM Pharma | 250.52B |
| DAE HWA Pharmaceutical | 213.88B |
| GC WellBeing | 196.98B |
| CellBion | 183.38B |
| NOVAREX | 178.56B |
| Vivozon Pharmaceutical | 178.09B |
| HYUNDAI BIOLAND | 150.00B |